Last updated
Revenue
R&D Expenses
Operating CF
Total Assets
Total Liabilities
Equity
Shares Out.
D/E Ratio
Dilution Watch
Financials
52W LOW $1.0352W HIGH $13.49
Volume
198.03 K
Value Traded
1.66 M
Short % Float
9.68%
Days to Cover
3.2
+16.94%Week
-19.07%1 Month
+8.21%3 Month
+34.26%6 Month
-98.3%5 Year
-100%All Time
Cash Data
- Monthly Burn
- Burn Trend
- Dilution Risk
- SEC Filing
Key Stats
Market Cap
100.26 M
EPS (TTM)
-21.87
P/E Ratio
-
Ent. Value
78.94 M
Total Shares
11.59 M
Float Shares
7.86 M
Insiders
32.19%
Institutions
4.93%
Upcoming Catalysts
FDA decisions, readouts and PDUFA dates · scored by probability of approval
| Catalyst | Drug / Treatment | Stage | Prob. of Approval | Description | Drug Type | Therapeutic Area | Source |
|---|
PoA blends historical approval base rates, trial design score and FDA review track record.
AGPU Catalyst Timeline
Dated clinical, regulatory and corporate events for Axe Compute Inc.
Past FDA Catalysts and PDUFA Decisions
How AGPU actually traded into and out of each decision
| Date | Drug | Catalyst | Stage | Reaction | Event Move % | Best Trade % |
|---|---|---|---|---|---|---|
| No matching catalysts | ||||||
Reaction: 30 trading days around the event · Event Move: close to close on decision day · Best Trade: peak run-up from entry 10 days before the decision
Drug Pipeline Intelligence
No drug pipeline
Axe Compute Inc. is a medical device company. The clinical trials it takes part in test other companies' drugs, so it has no drug pipeline of its own to score.
Clinical Trial Results
Readouts, endpoints and source filings for every AGPU program
| Drug Name | Indication | Phase | Date | Trial Results Summary | Title | Source |
|---|
Inside Trades
| Insider | Side | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| Zhu TheodoreDirector | Buy | 5,000 16,314 held | $10.88 | 09/08/2026 |
Hedge Fund 13F Activity
Hedge Funds invested in AGPU
| Fund | % of Portfolio | Current MV | Shares Owned | Activity |
|---|---|---|---|---|
| No hedge fund reported a 13F position in AGPU for Q2 2026. | ||||
Ownership Trends
AGPU Short Interest
Shares sold short, counted twice a month.
9.68%
Short % of Float
of tradable shares sold short
761.1K
Shares Sold Short
+6.7% vs prior count
3.2 Moderate
Days to Cover
trading days of normal volume to buy every short share back
237.8K
Avg Daily Volume
the average used for days to cover
Options Data
Option Volume
Open Interest
Call OI
Put OI
Put-Call Ratio
OI 30-day avg
Today vs avg
Option Volume
Call Vol
Put Vol
Put-Call Ratio
Vol 30-day avg
Today vs avg
Option Chain Statistics
| Expiry | Call Vol | Put Vol | Vol P/C | Call OI | Put OI | OI P/C | IV Call | IV Call OI-Wtd | IV Call Vol-Wtd | IV Put | IV Put OI-Wtd | IV Put Vol-Wtd |
|---|
Real-Time Option Chain
| Calls | Strike | Puts | ||||
|---|---|---|---|---|---|---|
| Last | Vol | OI | Last | Vol | OI | |
| No data available | ||||||
Calls vs Puts by Expiry
CallsPutsLog scale
Competitive positioning
How AGPU ranks across every disease it competes in
Competitive Position is a premium feature
See how AGPU ranks against every competitor across each disease it develops in: phase, best drug, trials and likelihood of approval.
Start free trialAGPU News
AGPU▲ +13.2%today
Axe Compute to Host Q3 2026 Financial Results Conference Call
Axe Compute will hold a conference call on November 17, 2026, to discuss its financial results for Q3 2026. The call will feature CEO Christopher Miglino, President Kyle Okamoto, and CFO Jeremy Yaukey-Witter. Investors can join via dial-in or webcast, with a replay available afterward.
Read more →AGPUAxe Compute Chooses Miami as Global Headquarters for its Neocloud AI Infrastructure Business
Axe Compute Inc. has relocated its headquarters from Pittsburgh to Miami, enhancing its presence in a key international business center. This move allows for closer proximity to partners and investors, supporting the company's global operations. CEO Christopher Miglino emphasized Miami's growth as a tech hub and its favorable conditions for attracting talent.
Read more →AGPU▼ -11.6%on this news
Axe Compute Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Axe Compute Inc. announced the approval of stock options for three new non-executive employees. The grant includes 100,000 shares with an exercise price of $8.60, matching the previous closing price. The options vest over three years, promoting long-term commitment from the new hires.
Read more →AGPU▼ -11%on this news
Axe Compute Signs Penguin Solutions as Strategic Partner to Accelerate Delivery of Next-Generation AI Infrastructure as Demand for Axe Compute Build Surges
Axe Compute has partnered with Penguin Solutions to enhance its AI infrastructure deployment capabilities. This multi-year agreement aims to address the growing demand for Axe Compute Build, with contracted projects surpassing $3.45 billion. The collaboration will leverage Penguin's expertise to expedite project delivery and operational support for large GPU clusters.
Read more →AGPU▼ -8%on this news· ran to -28% by day 3shared move
Axe Compute (NASDAQ: AGPU) to Ring the Nasdaq Stock Market Opening Bell on October 12, 2026
Axe Compute Inc. (NASDAQ: AGPU) will ring the Nasdaq Opening Bell on October 12, 2026, celebrating its growth in AI infrastructure. CEO Christopher Miglino highlighted over $3.45 billion in signed contracts and ongoing expansion of GPU compute capacity. The event will take place at the Nasdaq MarketSite in Times Square, New York City.
Read more →AGPU▲ +7.5%on this news
Axe Compute Takes Full Ownership of Georgia AI Cluster, Significantly Increasing the Contract’s Expected Free Cash Flow and Gross Margin
Axe Compute Inc. has acquired 100% ownership of the Georgia AI Cluster from Duos Technologies, eliminating an $87.8 million asset-backed loan. The customer agreement has been extended to five years, with an anticipated revenue of $364.6 million. This strategic acquisition is expected to improve gross margins significantly.
Read more →AGPUAxe Compute Receives More Than $184 Million in Customer Prepayments and Signs Over $266 Million in New AI Infrastructure Contracts Since Q2 Earnings Call
Axe Compute Inc. announced over $184 million in customer prepayments and $266 million in new AI infrastructure contracts since its Q2 earnings call. The total value of contracts signed in the past seven months has surpassed $3.45 billion. The new agreements include advanced hardware and support for AI workloads, reflecting strong demand in the market.
Read more →AGPUAxe Compute Sells Helomics AI Cancer Diagnostics Lab Business to DataMEDS AI, Completing Transition to Neocloud GPU-as-a-Service platform
Axe Compute Inc. has sold its Helomics AI cancer diagnostics lab to DataMEDS AI in an all-stock transaction. This move allows Axe Compute to focus entirely on its GPU-as-a-Service business while retaining an equity stake in DataMEDS. The sale marks the completion of Axe Compute's strategic transformation.
Read more →AGPUAxe Compute Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Axe Compute Inc. announced the grant of a non-qualified stock option for 60,000 shares to a new employee under Nasdaq Listing Rule 5635(c)(4). The option, priced at $10.67 per share, has a ten-year term with a vesting schedule. This move indicates the company's commitment to attracting talent.
Read more →AGPUAxe Compute Receives $317 Million in Customer Prepayments Under Global AI Infrastructure Contracts
Axe Compute Inc. announced it received over $317 million in customer prepayments, accelerating its AI infrastructure deployment across the U.S. and Europe. The company has secured over $3 billion in contracts, which are expected to generate significant revenue starting late Q4 2026. This funding reduces external financing needs and enhances revenue visibility.
Read more →AGPU▲ +28.4%on this newsshared move
Axe Compute and Duos Technologies Enter into Agreements For 55 MW of New AI Data Center Capacity Across Multiple U.S. Locations
Axe Compute and Duos Technologies announced agreements for 55 MW of AI data center capacity across multiple U.S. locations. The deals, worth over $500 million, aim to meet the accelerating demand for AI infrastructure. Axe Compute will also invest in the projects, allowing for greater control over capacity and costs. Initial project readiness is expected in late 2026.
Read more →AGPU▲ +10.2%on this news· ran to +189% by day 3
Axe Compute Inc. Reports Full-Year 2025 Financial Results
Axe Compute Inc. reported its financial results for the fiscal year ended December 31, 2025, marking a pivotal year of transformation. The company raised $343.5 million to fund its digital asset treasury strategy and established a distributed GPU network. Despite a net loss of $232.9 million, Axe Compute aims to drive revenue growth in 2026 through various operational priorities.
Read more →AGPUAxe Compute to Host Annual Report Conference Call
Axe Compute (NASDAQ: AGPU) will announce its fiscal year 2025 financial results on March 31, 2026, and host a conference call on April 1, 2026. The call will discuss financial performance, operational progress, and future business outlook. The company focuses on building a globally distributed AI compute infrastructure.
Read more →AGPUAxe Compute Explores Strategic Options for its Helomics Business as Company Sharpens AI Compute Focus
Axe Compute, Inc. is exploring strategic options for its Helomics Business with the help of Cardiff Advisory LLC. This review aims to maximize shareholder value from its biobank platform while the company focuses on its AI compute strategy. The process may lead to various transactions, although no guarantees are provided.
Read more →AGPU▲ +6.1%on this news
Axe Compute Appoints Christopher Miglino as Chief Executive Officer, Ushering in a New Era of Decentralized Compute
Axe Compute has appointed Christopher Miglino as its new CEO, marking a significant step towards enhancing its decentralized compute and digital infrastructure capabilities. Miglino's leadership aims to expand the company's operations in the AI Compute market, focusing on institutionalized platforms and decentralized GPU compute. His appointment reflects AGPU's commitment to innovation and growth in the evolving landscape of technology.
Read more →AGPUThis presentation contains "forward - looking statements" as de ned by the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act, and Section 21E of
Predictive Oncology has outlined its digital asset treasury strategy in a presentation, identifying the Aethir ecosystem as a key area for growth. The company is positioned to benefit from significant increases in AI infrastructure spending projected to reach $2.8 trillion by 2029. However, the accuracy of future outcomes remains uncertain, with various risks and assumptions involved. The firm also maintains a substantial amount of ATH tokens, which it plans to utilize to generate revenue through multiple strategies.
Read more →AGPUSECURITIES PURCHASE AGREEMENT
Predictive Oncology, Inc. has entered into a Securities Purchase Agreement to issue and sell shares and/or pre-funded warrants to designated purchasers. This agreement, dated for September 2025, outlines terms compliant with the Securities Act and includes a Registration Rights Agreement to provide specific rights regarding the shares issued. The deal aims to enhance the company's capital structure and investor relations.
Read more →AGPUCorporate Overview Cancer Quest 2020 Project September 2019 PREDICTIVE ONCOLOGY P O A I
Corporate Overview Cancer Quest 2020 Project September 2019 PREDICTIVE ONCOLOGY P O A I Forward looking statements This presentation includes "forward - looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These statements include but a
Read more →AGPUA leader in Artificial Intelligence (AI) - driven, knowledge - based precision medicine AIPT Corporate Presentation May 2019
A leader in Artificial Intelligence (AI) - driven, knowledge - based precision medicine AIPT Corporate Presentation May 2019 Forward Looking Statements 2 This presentation includes "forward - looking statements" within the meaning of the Private Securities Litigation Reform Act
Read more →AGPUPrecision Therapeutics Reports First Quarter 2019 Financial Results and Provides Corporate Update Management to Host Conference Call to Review Financial Results and Provide Corporate Update at 4:30PM Today MINNEAPOLIS
Precision Therapeutics Reports First Quarter 2019 Financial Results and Provides Corporate Update Management to Host Conference Call to Review Financial Results and Provide Corporate Update at 4:30PM Today MINNEAPOLIS, May 15, 2019 (GLOBE NEWSWIRE) -- Precision Therapeutics
Read more →About Axe Compute Inc.
Headquarters91 43RD STREET, PITTSBURGH, PA, 15201
BIOPHARMAWATCH ELITE
Trade the next AGPU catalyst before the market reprices
Every FDA decision, PoA score, 13F move and dilution flag on this page, for 1,100+ biotech tickers. From $24/mo billed annually.
Cancel anytime